Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07467226) titled 'MATERNAL SERUM CADHERIN-6 AS A PREDICTOR OF PREECLAMPSIA' on March 9.

Study Type: Observational

Primary Sponsor: Samsun University

Condition: Preeclampsia Pregnancy Biomarker Cadherin-6

Intervention: Other: Maternal serum cadherin-6 measurement

Recruitment Status: Not recruiting

Date of First Enrollment: January 1, 2024

Target Sample Size: 150

Countries of Recruitment: Turkey (Turkiye)

To know more, visit https://clinicaltrials.gov/study/NCT07467226

Published by HT Digital Content Services with permission from Health Daily Digest....